LIU Jian-lin, WU Qiu-shuang, WANG Yi-tao, et al. Extraction of Panax Chinese Medicines and Their Anti-cancer Effects on HEY Ovarian Cancer Cells[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(8): 105-110.
DOI:
LIU Jian-lin, WU Qiu-shuang, WANG Yi-tao, et al. Extraction of Panax Chinese Medicines and Their Anti-cancer Effects on HEY Ovarian Cancer Cells[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(8): 105-110. DOI: 10.13422/j.cnki.syfjx.2016080105.
Extraction of Panax Chinese Medicines and Their Anti-cancer Effects on HEY Ovarian Cancer Cells
Objective: To extract effective components from Panax ginseng
P. quinquefolium
P. japonicas and P. notoginseng
and compare their inhibitory activities against ovarian cancer HEY cells. Method: Water and ethanol extracts of P. ginseng
P. quinquefolium
P. japonicas and P. notoginseng were prepared by reflux extraction with water and ethanol. Total saponins and their panaxadiol saponin (PDS) and panaxtrol saponin (PTS) fractions were prepared from 70% ethanol water extracts of above herbs using macroporous resin chromatography. 3-(4
5-dimethyl-2-thiazolyl)-2
5-diphenyl-2-H-tetrazolium bromide (MTT) assay was used to detect the activities of these extracts and fractions against HEY ovarian cancer cells. propidium iodide(PI) staining was used to detect the effect of extracts on cell cycle distribution
and western blot was performed to detect their effect on expression of cell cycle related proteins. In addition
scratch assay was conducted to detect the effect of extracts on cell migration. Result: All the indicated extracts showed varied activities against HEY cells. Among them
panaxadiol saponin of P. quinquefolium (PDSPQ)
total saponin of P. japonicas (TSPJ)
ethanol extract of P. ginseng (EEPG)
total saponin of P. ginseng (TSPG)
and panaxadiol saponin of of P. ginseng(PDSPG) showed relative higher inhibitory rate against HEY cells
with 45.59%
45.78%
50.48%
46.98% and 64.36%
respectively. Further
PDSPQ
TSPG
and PDSPG could down-regulate the expressions of CDK4
CDK6
and cyclin D1 to different degrees
but had no significant effect on the migration of HEY cells. Conclusion: Fractions with PDS were more effective on inhibiting HEY cells growth
and the mechanism may be associated with down-regulating the protein expressions of CDK4
Clinical Research on Guizhi Fulingwan in Treatment of Ovarian Cancer: A Review
Gypenoside L Regulates piR-hsa-2804461/FKBP8/Bcl-2 Axis to Promote Apoptosis and Inhibit Ovarian Cancer
Exploring Molecular Mechanism of Gypenoside L against Ovarian Cancer Based on Ferroptosis Pathway Mediated by Mature-tRNA-Asp-GTC/ATF3-LPCAT3
Molecular Mechanism of Treating Different Diseases with Same Treatment of Gypenoside L Affecting Oxidative Damage HUVEC and OVCAR-3 Through EGFR/STAT3/Glycolytic Pathway
Molecular Mechanism of Gypenoside L in Anti-Ovarian Cancer by Affecting GCK-Mediated Glycolytic Pathway
Related Author
GUAN Muxin
FENG Jiaxing
ZHU Mengyi
WANG Yu
WU Xiaoke
DONG Yuanguang
SUN Yinying
YUAN Mingdian
Related Institution
The First Affiliated Hospital of Heilongjiang University of Chinese Medicine
Heilongjiang University of Chinese Medicine
Liaoning Provincial Hospital of TCM
Liaoning University of Traditional Chinese Medicine(TCM)